Virginia Moyer
Virginia A. Moyer is an American academic, pediatrician and former chair of the US Preventative Services Task Force from 2011 to 2014 after being a member from 2003 to 2008.[1][2][3] Subsequently she was vice president of certification and quality at the American Board of Pediatrics. Her research focused on evidence medicine in pediatrics and adult healthcare. She was a professor of pediatrics at Baylor College of Medicine and director of academic pediatrics.[4] She rose to prominence when the task force recommended against routine screening with prostate specific antigen tests.[5][6] These recommendations were widely debated by urologists at the time who feared the recommendations may lead to increased deaths from prostate cancer.[7][8] Since leaving the panel she has argued against the policy of tying insurance coverage to task force recommendations due to fear of corrupting the process and lobbying by pharmaceutical companies. In particular she has argued along with other former chairs of the task force, that the improper designation of services such as Mylan's Epipen may lead to paradoxical harms.[9][10]
Education and background
[edit]Moyer graduated from Rice University with a bachelor's degree in Psychology in 1974, and subsequently studied medicine at Baylor College of Medicine.[11] She additionally has an Masters of Public Health from the University of Texas. She is a fellow of the American Academy of Pediatrics.[4]
Tenure as Chair of the US Preventative Services Task Force
[edit]Moyer was appointed in 2011 to a three-year term of the 16 member volunteer panel.[2] During her tenure a number of major decisions were enacted, and she served as the public. These included the decision to recommend against routine PSA screening for all age groups for prostate cancer detection. This was due to data that suggested the intervention may cause more harm on a population level than undetected cancers. These recommendations and the process of decision making were widely critiqued, especially by urologists and their professional association, the American Urological Association.[12] The recommendations were notable having received criticism from politicians including US Representative Newt Gingrich, who incorrectly asserted the panel lacked medical expertise.[13]
References
[edit]- ^ "Dr. Moyer to Receive Rice University's 2016 Distinguished Alumni Award | The American Board of Pediatrics". www.abp.org. Retrieved 2025-11-05.
- ^ a b "Dr. Moyer to lead U.S. Preventive Services Task Force". Retrieved 2025-11-04.
- ^ Park, Alice (2011-12-14). "People Who Mattered: Dr. Virginia A. Moyer". Time. ISSN 0040-781X. Retrieved 2025-11-05.
- ^ a b "Virginia Moyer, MD, MPH". Improvement Science Research Network. Retrieved 2025-11-05.
- ^ Moyer, Virginia A.; U.S. Preventive Services Task Force (2012-07-17). "Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement". Annals of Internal Medicine. 157 (2): 120–134. doi:10.7326/0003-4819-157-2-201207170-00459. ISSN 1539-3704. PMID 22801674.
- ^ "U.S. Panel Says No to Prostate Screening for Healthy Men (Published 2011)". 2011-10-06. Retrieved 2025-11-05.
- ^ Hensley, Scott (2011-10-07). "Panel Advises Against Prostate Cancer Test". NPR. Retrieved 2025-11-05.
- ^ "Local men will die if task force recommendations on prostate cancer screening are abided by". The Vindicator. Retrieved 2025-11-05.
- ^ Moyer, Virginia A.; LeFevre, Michael; Calonge, Ned (2016-12-20). "Is It Time for the USPSTF to Inform—But Not Determine—Coverage?". Annals of Internal Medicine. 165 (12): 876–877. doi:10.7326/M16-2304. ISSN 0003-4819. PMID 27723869.
- ^ "Rethinking Automatic Insurance Coverage For Preventive Health Care". NPR. 2016-10-10. Retrieved 2025-11-05.
- ^ "Rice alumna just in 'Time'". news2.rice.edu. Retrieved 2025-11-05.
- ^ Pollack, Andrew (2011-11-04). "For Prostate Screening Guidelines, Public Comments Are Private". Prescriptions Blog. Retrieved 2025-11-05.
- ^ Times, The New York (2011-10-12). "Fact Checking the Republican Debate on the Economy". The Caucus. Retrieved 2025-11-05.
| International | |
|---|---|
| National | |
| Other | |
 | This article needs additional or more specific categories. (November 2025) |